Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Monsanto Co. -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (2284)	7/16/1999 1:10:00 AM
From: JGoren	Read Replies (1) \| Respond to of 2539

Anecdotal Celebrex. Having read the many posts on the benefits of Celebrex over the NSAID's, I now have first-hand experience due to an injury that caused tendonitis. First, I was prescribed Daypro. Although it cut the inflammation, the side effects of the "cure" on my stomach were almost as bad as the original pain. A week later, I asked for a Cox-2 and my doctor was about to prescribe Vioxx but being a loyal shareholder I asked for Celebrex. So far so good. By the way, the difference in price was about a dollar, Celebrex being more expensive. Of course, the Cox-2's are a bit more than twice the price of the Daypro. Curiously, I was prescribed 200 mg.--one pill per day. My recollection is that Celebrex was supposed to be dosed twice a day. I've done my bit for the company, so why does the stock price languish?